Sign Up to like & get
recommendations!
1
Published in 2022 at "Lung cancer"
DOI: 10.2139/ssrn.4134030
Abstract: BACKGROUND Neoadjuvant chemo-immunotherapy has got clinical benefits in parts of resectable non-small cell lung cancer (NSCLC) patients. The factors affecting the pathological response of NSCLC remain controversial. METHODS A retrospective study of 59 patients with…
read more here.
Keywords:
lung cancer;
cell;
neoadjuvant chemo;
chemo immunotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15988
Abstract: Abstract Background/Aim: The benefit of neoadjuvant (chemo) radiotherapy for locally advanced upper rectal tumors remains controversial. Thus, we aimed to evaluate the outcome of patients with stage II or-III upper rectal cancer undergoing neoadjuvant (chemo)…
read more here.
Keywords:
upper rectal;
neoadjuvant chemo;
rectal cancer;
chemo radiotherapy ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10123247
Abstract: Background: Neoadjuvant chemo-radiotherapy (nCRT) represents the standard of care for locally advanced rectal cancer (LARC); however, there exists no biomarker that can predict the cancer’s response to treatment as less than 20% of patients experience…
read more here.
Keywords:
locally advanced;
chemo radiotherapy;
neoadjuvant chemo;
rad50 ... See more keywords